References

Adams S, Leblanc P, Datta SK. Junctional region sequences of T-cell receptor beta chain genes expressed by pathogenic anti-DNA autoantibody-inducing helper T cells from lupus mice: possible selection by cationic autoantigens. Proc Natl Acad Sci USA 88:11271-11275,1991.

Amiral J, Bridey F, Dreyfus M, Vissac AM, Fressinaud E, Wolf M, Meyer D. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia [letter]. Thromb Haemost 68:95-96, 1992.

Amiral J, Bridey F, Wolf M. Antibodies to macromolecular platelet factor-4 heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thromb Haemost 73:21-28,1995.

Amiral J, Marfaing-Koka A, Wolf M, Alessi MC, Tardy B, Boyer-Neumann C, Vissac AM, Fressinaud E, Poncz M, Meyer D. Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocyto-penia. Blood 88:410-416, 1996a.

Amiral J, Wolf M, Fischer AM, Boyer-Neumann C, Vissac AM, Meyer D. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia. Br J Haematol 92:954-959, 1996b.

Arepally G, Reynolds C, Tomaski A, Amiral J, Jawad A, Poncz M, Cines DB. Comparison of PF4—heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 104:648-654, 1995.

Arepally G, McKenzie SE, Jiang XM, Poncz M, Cines DB. FcyRIIA H/R131 polymorphism, subclass-specific IgG antiheparin/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis. Blood 89: 370-375,1997.

Arepally GM, Mayer IM. Antibodies from patients with heparin-induced thrombocyto-penia stimulate monocytic cells to express tissue factor and secrete interleukin-8. Blood 98:1252-1254, 2001.

Aster RH. Heparin-independent activation of platelets by HIT antibodies: a clue to the etiology of delayed thrombocytopenia/thrombosis in patients given heparin? J Thromb Haemost 3:2166-2167, 2005.

Bacsi S, De Palma R, Visentin GP, Gorski J, Aster RH. Complexes of heparin and platelet factor 4 specifically stimulate T cells from patients with heparin-induced thrombocytopenia/thrombosis. Blood 94:208-215, 1999.

Bacsi S, Geoffrey R, Visentin GP, De Palma R, Aster RH, Gorski J. Identification of T cells responding to a self-protein modified by an external agent. Hum Immunol 62:113-124, 2001.

Broxmeyer HE, Sherry B, Cooper S, Lu L, Maze R, Beckmann MP, Cerami A, Ralph P. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression. J Immunol 150:3448-3458,1993.

Cadroy Y, Amiral J, Raynaud H, Brunei P, Mazaleyrac A, Sauer M, Sie P. Evolution of antibodies anti-PF4/heparin in a patient with a history of heparin-induced thrombocytopenia reexposed to heparin [letter]. Thromb Haermost 71:247-251,1994.

Cochet M, Pannetier C, Regnault A, Darche S, Leclerc C, Kourilsky P. Molecular detection and in vivo analysis of the specific T cell response to a protein antigen. Eur J Immunol 22:2639-2647, 1992.

Crow MK, DelGiudice-Asch G, Zehetbauer JB, Lawson JL, Brot N, Weissach H, Elkon KB. Autoantigen-specific T cell proliferation induced by the ribosomal P2 protein in patients with systemic lupus erythematosus. J Clin Invest 94:345-352, 1994.

de Waal LP, van Dalen CM, Engelfriet CP, von dem Borne AEGK. Alloimmunization against the platelet specific Zwa antigen, resulting in neonatal alloimmune thrombo-cytopenia or posttransfusion purpura, is associated with the supertypic DRw52 antigen including DR3 and DRw6. Hum Immunol 17:45-53,1986.

Doi T, Greenberg SM, Rosenberg RD. Structure of the rat platelet factor 4 gene: a marker for megakaryocyte differentiation. Mol Cell Biol 7:898-904, 1987.

Fleischer JE, Grage-Griebenow B, Kasper H, Heine M, Ernst E, Brandt HD, Flad, Petersen F. Platelet factor 4 inhibits proliferation and cytokine release of activated human T cells. J Immunol 169:770-777, 2002.

Gomes PB, Dietrich CP. Distribution of heparin and other sulfated glycosaminoglycans in vertebrates. Comp Biochem Physiol 73B:857-863, 1982.

Green D, Harris K, Reynolds N, Roberts M, Patterson R. Heparin immune thrombocy-topenia: evidence for heparin-platelet complex as the antigenic determinate. J Lab Clin Med 91:167-175, 1978.

Greinacher A, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: no association of immune response with HLA. Vox Sang 65:151-153,1993.

Greinacher A, Michels I, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: the antibody is not heparin specific. Thromb Haemost 67:545-549,1992.

Greinacher A, Potzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost 71:247-251, 1994.

Greinacher A, Alban S, Dummel V, Franz G, Mueller-Eckhardt C. Characterization of the structural requirements for a carbohydrate-based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thrombocytopenia. Thromb Haemost 74:886-892, 1995.

Greinacher A, Gopinadhan M, Gunther JU, Omer-Adam MA, Strobel U, Warkentin TE, Papastavrou G, Weitschies W, Helm CA. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies. Arterioscler Thromb Vasc Biol 26:2386-2393, 2006.

Handin RJ, Cohen HJ. Purification and binding properties of human platelet factor four. J Biol Chem 251:4273-4282, 1976.

Heeger PS, Backstrom JT. Heparin flushes and thrombocytopenia. Ann Intern Med 105:143, 1986.

Henn V, Slupsky JR, Gräfe M, Anagnostopoulos I, Förster R, Müller-Berghaus G, Kroczek RA. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591-594, 1998.

Höök M, Kjellen L, Johansson S, Robinson J. Cell-surface glycosaminoglycans. Annu Rev Biochem 53:847-869, 1984.

Horsewood P, Warkentin TE, Hayward CPM, Kelton JG. The epitope specificity of heparin-induced thrombocytopenia. Br J Haematol 95:161-167, 1996.

Hrushesky WJ. Subcutaneous heparin-induced thrombocytopenia. Arch Intern Med 138:1489-1491, 1978.

Ibel K, Polland GA, Baldwin JP, Pepper DS, Luscombe M, Holbrook JJ. Low resolution structure of the complex of human platelet factor 4 with heparin determined by small-angle neutron scattering. Biochim Biophys Acta 870:58-63, 1986.

Ito Y, Nieda M, Uchigata Y, Nishimura M, Tokunaga K, Kuwata S, Obata F, Tadokoro K, Hirata Y, Omori Y, Juji T. Recognition of human insulin in the context of HLA DRB 1*0406 products by T cells of insulin autoimmune syndrome patients and healthy donors. J Immunol 151:5770-5776, 1993.

Kelton JG, Warkentin TE. Heparin-induced thrombocytopenia. Diagnosis, natural history, and treatment options. Postgrad Med 103:169-171, 175-178, 1998.

Kelton JG, Sheridan D, Santos A, Smith J, Steeves K, Smith C, Brown C, Murphy WG. Heparin-induced thrombocytopenia: laboratory studies. Blood 72:925-930, 1988.

Kelton JG, Smith JW, Warkentin TE, Hayward CPM, Denomme GA, Horsewood P. Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood 83:3232-3239,1994.

Kuwana M, Medsger TA Jr, Wright TM. T and B cell collaboration is essential for the autoantibody response to DNA topoisomerase I in systemic sclerosis. J Immunol 155:2703-2714, 1995a.

Kuwana M, Medsger TA Jr, Wright TM. T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors. J Clin Invest 96:586-596, 1995b.

Lecompte T. Thrombocytopenia associated with low-molecular-weight heparin [letter]. Lancet 338:1217, 1991.

Li ZQ, Liu W, Park KS, Sachais BS, Arepally GM, Cines DB, Poncz M. Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody. Blood 99:1230-1236, 2002.

Ling E, Warkentin TE. Intraoperative heparin flushes and subsequent acute heparin induced thrombocytopenia. Anesthesiology 89:1567-1569, 1998.

Liu CY, Gorski J, Aster RH, Visentin GP. Identification of a T-cell receptor CDR3 motif associated with the cellular immune response in heparin-induced thrombocytope-nia/thrombosis [abstr]. Blood 96(suppl):817a, 2000.

Liu CY, Gorski J, Aster RH, Visentin GP. T cells from a patient experiencing heparin induced thrombocytopenia/thrombosis (HIT/T) share a common T cell receptor CDR3 motif (GTG) when cultured in the presence of the putative antigen: PF4-heparin [abstr]. Thromb Haemost July(suppl):OC217, 2001.

Liu CY, Battaglia M, Lee SH, Sun QH, Aster RH, Visentin GP. Platelet factor 4 differentially modulates CD4+CD25+ (regulatory) versus CD4+CD25~ (nonregulatory) T cells. J Immunol 174:2680-2686, 2005.

Loscalzo J, Melnick B, Handin RI. The interaction of platelet factor 4 and glycosami-noglycans. Arch Biochem Biophys 240:446-455, 1985.

Luster AD. Chemokins—chemotactic cytokines that mediate inflammation. N Engl J Med 338:436-445, 1998.

Maccarana M, Lindahl U. Mode of interaction between platelet factor 4 and heparin. Glycobiology 3:271-277, 1993.

Mach F, Schonbeck U, Bonnefoy JY, Pober JS, Libby P. Activation of monocyte/ macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 96: 396-399, 1997.

Maslanka K, Piatek T, Gorski J, Yassai M, Gorski J. Molecular analysis of T cell repertoires. Spectra types generated by multiplex polymerase chain reaction and evaluated by radioactivity or fluorescence. Hum Immunol 44:28-34, 1995.

Maslanka K, Yassai M, Gorski J. Molecular identification of T cells that respond in a primary bulk culture to a peptide derived from a platelet glycoprotein implicated in neonatal alloimmune thrombocytopenia. J Clin Invest 98:1802-1808, 1996.

Mayo KH, Ilyina E, Roongta V, Dundas M, Joseph J, Lai CK, Maione T, Daly TJ. Heparin binding to platelet factor-4. An NMR and site-directed mutagenesis study: arginine residues are crucial for binding. Biochem J 312:357-365,1995a.

Mayo KH, Roongta V, Ilyina E, Milius R, Barker S, Quinlan C, La Rosa G, Daly TJ. NMR solution structure of the 32-kDa platelet factor 4 ELR-motif N-terminal chimera: a symmetric tetramer. Biochemistry 34:11399-11409, 1995b.

Metcalfe DD, Lewis RA, Silbert JE, Rosenberg RD, Wasserman SI, Austen KF. Isolation and characterization of heparin from human lung. J Clin Invest 64: 1537-1543, 1979.

Mohan C, Adams S, Stanik V, Datta SK. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 177:1367-1381, 1993.

Mueller-Eckhardt C, Kiefel V, Kroll H, Mueller-Eckhardt G. HLA-DRw6, a new immune response marker for immunization against the platelet alloantigen Bra. Vox Sang 57:90-91, 1989.

Newman PM, Chong BH. Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation. Blood 96:182-187, 2000.

Pannetier C, Cochet M, Darche S, Casrouge A, Zöller M, Kourilsky P. The sizes of CDR3 hypervariable regions of the murine T-cell receptor ß chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci USA 90: 4319-4323, 1993.

Poncz M, Surrey S, LaRocco P, Weiss MJ, Rappaport EF, Conway TM, Schwartz E. Cloning and characterization of platelet factor 4 cDNA derived from a human erythroleukemic cell line. Blood 69:219-223, 1987.

Pouplard C, Lochmann S, Renard B, Herault O, Colombat P, Amiral J, Gruel Y. Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia. Blood 97:3300-3302, 2001.

Prechel MM, McDonald MK, Jeske WP, Messmore HL, Walenga JM. Activation of platelets by heparin-induced thrombocytopenia antibodies in the serotonin release assay is not dependent on the presence of heparin. J Thromb Haemost 3:2168-2175, 2005.

Rauova L, Poncz M, McKenzie SE, Reilly MP, Arepally G, Weisel JW, Nagaswami C, Cines DB, Sachais BS. Ultra large complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia. Blood 105:131-138, 2005.

Rauova L, Zhai L, Kowalska MA, Arepally GM, Cines DB, Poncz M. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications. Blood 107:2346-2353, 2006.

Rollins BJ. Chemokines. Blood 90:909-928, 1997.

St. Charles R, Walz DA, Edwards BFP. The three-dimensional structure of bovine platelet factor 4 at 3.0-Ä resolution. J Biol Chem 264:2092-2099,1989.

Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270:27348-27357, 1995.

Stringer SE, Gallagher JT. Specific binding of the chemokine platelet factor 4 to heparan sulfate. J Biol Chem 272:20508-20514, 1997.

Stuckey JA, St. Charles R, Edwards DFP. A model of the platelet factor 4 complex with heparin. Proteins 14:277-287, 1992.

Suh JS, Malik MI, Aster RH, Visentin GP. Characterization of the humoral immune response in heparin-induced thrombocytopenia. Am J Hematol 54:196-201,1997.

Suh JS, Aster RH, Visentin GP. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis recognize different epitopes on heparin:platelet factor 4 complexes. Blood 91:916-922, 1998.

Suvarna S, Rauova L, McCracken EK, Goss CM, Sachais BS, McKenzie SE, Reilly MP, Gunn MD, Cines DB, Poncz M, Arepally G. PF4/heparin complexes are T cell-dependent antigens. Blood 106:929-931, 2005.

Tardy B. Thrombocytopenia associated with low-molecular-weight heparin [letter]. Lancet 338:1217, 1991.

Visentin GP. Heparin-induced thrombocytopenia: molecular pathogenesis. Thromb Haemost 82:448-456, 1999.

Visentin GP, Ford SE, Scott PJ, Aster RH. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 93:81-88, 1994.

Visentin GP, Malik M, Cyganiak KA, Aster RH. Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin: platelet factor 4 complexes. J Lab Clin Med 128:376-383, 1996.

Visentin GP, Moghaddam M, Beery SE, McFarland JG, Aster RH. Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia thrombosis. J Lab Clin Med 138:22-31, 2001.

Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 112:676-692,1997.

Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 121:535-555, 2003.

Warkentin TE, Kelton JG. Heparin-induced thrombocytopenia. Prog Hemost Thromb 10:1-34,1991.

Warkentin TE, Kelton JG. Temporal aspects of heparin-induced-thrombocytopenia. N Engl J Med 344:1286-1292, 2001.

Warkentin TE, Hayward CPM, Boshkov LK, Santos AV, Sheppard JI, Bode AP, Kelton JG. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 84:3691-3699, 1994.

Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost 79:1-7, 1998.

Yamamoto S, Koide M, Matsuo M, Suzuki S, Ohtaka M, Saika S, Matsuo T. Heparin-induced thrombocytopenia in hemodialysis patients. Am J Kidney Dis 28:82-85, 1996.

Zhang X, Chen L, Bancroft DP, Lai CK, Maione TE. Crystal structure of recombinant human platelet factor 4. Biochemistry 33:8361-8366, 1994.

Ziporen L, Li ZQ, Park KS, Sabnekar P, Liu WY, Arepally G, Shoenfeld Y, Kieber Emmons T, Cines DB, Poncz M. Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia. Blood 92:3250-3259,1998.

Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12:121-127, 2000.

Zucker MB. Effect of heparin on platelet function. Thromb Diath Haemorrh 33:63-65, 1975.

How To Bolster Your Immune System

How To Bolster Your Immune System

All Natural Immune Boosters Proven To Fight Infection, Disease And More. Discover A Natural, Safe Effective Way To Boost Your Immune System Using Ingredients From Your Kitchen Cupboard. The only common sense, no holds barred guide to hit the market today no gimmicks, no pills, just old fashioned common sense remedies to cure colds, influenza, viral infections and more.

Get My Free Audio Book


Post a comment